Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
IBEX Stock Forecast 2026-2027
$29.72
Current Price
$400.24M
Market Cap
Buy 0
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to IBEX Price Targets
+34.6%
To High Target of $40.00
+26.2%
To Median Target of $37.50
+17.8%
To Low Target of $35.00
IBEX Price Momentum
+4.4%
1 Week Change
+6.1%
1 Month Change
+27.3%
1 Year Change
-22.2%
Year-to-Date Change
-30.9%
From 52W High of $42.99
+31.3%
From 52W Low of $22.63
📊 TOP ANALYST CALLS
Did IBEX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Ibex is one of their latest high-conviction picks.
Latest IBEX Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, IBEX has a neutral consensus with a median price target of $37.50 (ranging from $35.00 to $40.00). The overall analyst rating is Buy (6.0/10). Currently trading at $29.72, the median forecast implies a 26.2% upside. This outlook is supported by 0 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Daniel R. Perlin at RBC Capital, projecting a 34.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
IBEX Analyst Ratings
0
Buy
2
Hold
0
Sell
IBEX Price Target Range
Low
$35.00
Average
$37.50
High
$40.00
Current: $29.72
Latest IBEX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for IBEX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 10, 2025 | RBC Capital | Daniel R. Perlin | Sector Perform | Maintains | $40.00 |
| Sep 12, 2025 | RBC Capital | Daniel R. Perlin | Sector Perform | Maintains | $39.00 |
| May 12, 2025 | Baird | David Koning | Neutral | Downgrade | $30.00 |
| Feb 7, 2025 | RBC Capital | Daniel Perlin | Sector Perform | Maintains | $24.00 |
| Nov 8, 2024 | Baird | David Koning | Outperform | Maintains | $26.00 |
| Sep 16, 2024 | Baird | David Koning | Outperform | Maintains | $23.00 |
| Sep 13, 2024 | RBC Capital | Daniel Perlin | Sector Perform | Maintains | $20.00 |
| Apr 19, 2024 | Baird | David Koning | Outperform | Maintains | $20.00 |
| Feb 9, 2024 | Truist Securities | Tobey Sommer | Buy | Maintains | $22.00 |
| Feb 9, 2024 | Piper Sandler | Arvind Ramnani | Neutral | Reiterates | $17.00 |
| Nov 10, 2023 | Piper Sandler | Arvind Ramnani | Neutral | Downgrade | $17.00 |
| Nov 10, 2023 | RBC Capital | Daniel Perlin | Sector Perform | Maintains | $19.00 |
| Sep 18, 2023 | Piper Sandler | Arvind Ramnani | Overweight | Maintains | $17.00 |
| Sep 14, 2023 | Baird | David Koning | Outperform | Maintains | $23.00 |
| Sep 14, 2023 | RBC Capital | Daniel Ford | Sector Perform | Downgrade | $18.00 |
| Sep 14, 2023 | Citigroup | Ryan Potter | Neutral | Maintains | $18.00 |
| Sep 14, 2023 | Truist Securities | Tobey Sommer | Buy | Maintains | $25.00 |
| Jun 9, 2023 | Baird | Outperform | Maintains | $N/A | |
| Jun 7, 2023 | Baird | David Koning | Outperform | Maintains | $28.00 |
| Jun 1, 2023 | Baird | Outperform | Maintains | $N/A |
IBEX Limited (IBEX) Competitors
The following stocks are similar to Ibex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
IBEX Limited (IBEX) Financial Data
IBEX Limited has a market capitalization of $400.24M with a P/E ratio of 9.9x. The company generates $603.27M in trailing twelve-month revenue with a 7.3% profit margin.
Revenue growth is +16.7% quarter-over-quarter, while maintaining an operating margin of +9.3% and return on equity of +33.6%.
Valuation Metrics
Market Cap
$400.24M
Enterprise Value
$447.29M
P/E Ratio
9.9x
PEG Ratio
0.2x
Price/Sales
0.7x
Growth & Margins
Revenue Growth (YoY)
+16.7%
Gross Margin
+29.0%
Operating Margin
+9.3%
Net Margin
+7.3%
EPS Growth
+31.8%
Financial Health
Cash/Price Ratio
+3.9%
Current Ratio
1.8x
Debt/Equity
41.6x
ROE
+33.6%
ROA
+12.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
IBEX Limited (IBEX) Business Model
About IBEX Limited
What They Do
Provides end-to-end customer lifecycle experience solutions.
Business Model
Ibex Ltd. operates a technology-enabled business model that combines customer service, technical support, and digital marketing to enhance customer experiences. The company generates revenue through its various offerings, such as ibex Connect for customer service and support, ibex Digital for customer acquisition, and ibex CX for managing customer experiences.
Additional Information
Founded in 2017 and based in Washington, DC, Ibex Ltd. serves a wide range of industries including banking, health tech, retail, and entertainment. It operates customer engagement centers globally, making it a versatile partner for businesses seeking to improve customer interactions and insights.
Company Information
Sector
Technology
Industry
Information Technology Services
Employees
39,000
CEO
Mr. Robert T. Dechant
Country
United States
IPO Year
2020
Website
www.ibex.coIBEX Limited (IBEX) Latest News & Analysis
Latest News
ibex to Showcase AI-Powered CX Solutions for Utilities at the IUCX Annual Conference 2026
7 days ago
Quick Summary
ibex (NASDAQ: IBEX) will showcase its AI-powered customer experience solutions at the IUCX Annual Conference in Tampa from April 14-16, aimed at enhancing utility customer engagement and reducing costs.
Why It Matters
Ibex's participation in the IUCX conference highlights its focus on innovation in AI-driven customer solutions, potentially boosting its market position and attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
IBEX Limited is shifting from BPO to HealthTech, with the segment growing 35% YoY to 17.4% of revenue. Q2 2026 revenues rose 16.7% YoY to $164.2M, and adjusted EBITDA margin improved to 12.6%.
Why It Matters
IBEX Limited's shift to HealthTech and strong growth in this segment indicate potential for higher profitability and revenue growth, making it a more attractive investment opportunity.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
In 2025, the Royce Capital Small-Cap Portfolio gained 8.9%, underperforming the small-cap value index's 12.6%. Seven of ten sectors positively contributed, with two top contributors in electronics contract manufacturing.
Why It Matters
The Royce Capital Small-Cap Portfolio's underperformance against the small-cap value index indicates potential concerns for fund management, while strong sector contributions suggest selective strengths in the portfolio.
Source: Seeking Alpha
Market Sentiment:
Positive
Royce Small-Cap Value Fund FY 2025: What Worked
1 month ago
Quick Summary
In 2025, seven of the Fund's 10 equity sectors positively impacted performance. Top contributors were in electronics contract manufacturing, but stock selection led to underperformance against the Russell 2000 Value.
Why It Matters
Positive sector performance suggests potential growth areas. Strong contributions from EMS indicate specific strengths in the portfolio, while stock selection challenges highlight risks for future returns.
Source: Seeking Alpha
Market Sentiment:
Positive
IBEX Limited (IBEX) Q2 2026 Earnings Call Transcript
2 months ago
Quick Summary
IBEX Limited reported its Q2 2026 earnings, detailing financial performance and key metrics. For specific figures and insights, refer to the full earnings call transcript.
Why It Matters
The Q2 2026 earnings call for IBEX Limited provides insights into the company's financial performance, growth prospects, and market trends, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
IBEX Limited reported its financial results for Q2 of fiscal year 2026, ending December 31, 2025. Further details on performance were not included in the excerpt.
Why It Matters
IBEX's financial results can indicate its performance and growth potential, impacting stock valuation and investor sentiment in the outsourcing sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About IBEX Stock
What is IBEX Limited's (IBEX) stock forecast for 2026?
Based on our analysis of 8 Wall Street analysts, IBEX Limited (IBEX) has a median price target of $37.50. The highest price target is $40.00 and the lowest is $35.00.
Is IBEX stock a good investment in 2026?
According to current analyst ratings, IBEX has 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $29.72. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for IBEX stock?
Wall Street analysts predict IBEX stock could reach $37.50 in the next 12 months. This represents a 26.2% increase from the current price of $29.72. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is IBEX Limited's business model?
Ibex Ltd. operates a technology-enabled business model that combines customer service, technical support, and digital marketing to enhance customer experiences. The company generates revenue through its various offerings, such as ibex Connect for customer service and support, ibex Digital for customer acquisition, and ibex CX for managing customer experiences.
What is the highest forecasted price for IBEX IBEX Limited?
The highest price target for IBEX is $40.00 from Daniel R. Perlin at RBC Capital, which represents a 34.6% increase from the current price of $29.72.
What is the lowest forecasted price for IBEX IBEX Limited?
The lowest price target for IBEX is $35.00 from at , which represents a 17.8% increase from the current price of $29.72.
What is the overall IBEX consensus from analysts for IBEX Limited?
The overall analyst consensus for IBEX is neutral. Out of 8 Wall Street analysts, 0 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $37.50.
How accurate are IBEX stock price projections?
Stock price projections, including those for IBEX Limited, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 20, 2026 3:07 AM UTC